Diagnoses of ADHD and autism have climbed steeply across the developed world for more than a decade, fuelling a bitter public argument about whether children are genuinely more affected — or simply more often labelled. Now, a large Danish study suggests the answer is not either/or, but a fundamental shift in who receives a diagnosis and why.

The research, reported by Science Daily, Medical Xpress and EurekAlert, found that children diagnosed with ADHD or autism today more closely resemble their peers in the general population than those diagnosed ten years earlier. In other words, the diagnostic net has widened — catching children with milder, more subtle presentations that would likely have gone unrecognised a decade ago.

What the Danish study found

Drawing on Denmark's national health registries — among the most comprehensive population datasets in the world — researchers compared the characteristics of children receiving ADHD and autism diagnoses in recent years with those diagnosed roughly a decade earlier. The headline result was a convergence: the newly diagnosed group looked less distinct from the average child.

That finding matters because it reframes the debate. If rising rates were driven purely by a true increase in the underlying conditions, you would expect the newly diagnosed to look much like the old cohort, only more numerous. Instead, the profile of the diagnosed population has drifted toward the population average, a pattern consistent with expanding diagnostic criteria, greater awareness among parents and teachers, and improved access to assessment.

Medical Xpress framed the result plainly: the profile of people diagnosed with ADHD and autism has changed over the past decade. MSN's coverage drew out the same thread under a more human headline — the types of people who get these diagnoses are different now.

A shifting boundary, not a simple explosion

Researchers who study diagnostic practice have long argued that conditions defined by behavioural criteria — rather than by a blood test or a scan — have inherently movable borders. As clinicians learn to recognise subtler presentations, and as families become more literate about neurodevelopment, the threshold for diagnosis drifts downward.

The study's central implication is that rising diagnosis rates partly reflect broader identification and changing diagnostic patterns, rather than only an increase in the underlying conditions.

The Telegraph approached the same story from a different angle, foregrounding one figure working to reverse the trend in diagnosis — a framing that places individual clinical judgement, rather than population statistics, at the centre of the narrative. (The full article was not accessible at the time of writing.) It is a reminder that the same dataset can support strikingly different stories: one about shifting populations, another about individual practice.

The sex gap is narrowing

One of the most striking subplots is demographic. As Yahoo reported, autism diagnoses are rising among women — but not among men. Historically, autism and ADHD were understood as predominantly male conditions, a bias baked into early research cohorts and diagnostic tools.

The new data suggests that widening identification is concentrated among girls and women, whose presentations are often more socially camouflaged and therefore missed by screening instruments designed around male-typical traits. If the overall rise in diagnoses is largely a female phenomenon, that points toward correction of a long-standing ascertainment gap rather than a sudden change in biology.

Biology remains complicated

Meanwhile, science coverage of autism's underlying mechanisms has grown markedly more cautious. News-Medical reported a study offering a "more nuanced picture" of the biological pathways linked to autism — a signal that researchers are moving away from single-gene or single-mechanism explanations toward models involving many interacting factors, each with small effects.

That complexity is precisely why diagnosis remains behavioural rather than biological. There is still no biomarker that can definitively confirm autism or ADHD, which is why the question of where the diagnostic line falls is ultimately a matter of clinical and social judgement.

AI enters the screening picture

Into that gap steps technology. As Inc. reported, a teenager has developed an AI tool that uses eye scans to screen for autism and ADHD. Eye-tracking research has long suggested that differences in gaze patterns and visual attention may correlate with neurodevelopmental conditions.

The promise is obvious: faster, cheaper, more objective triage that could shorten waiting lists. The risk is equally obvious. An algorithm trained on today's diagnostic labels inherits today's definitions — and if the boundary has already shifted once in a decade, a model trained on 2015 criteria may be screening for the wrong thing.

The overdiagnosis fight

The political stakes were underscored by a major UK review, expected — according to MSN — to reject widespread claims of "overdiagnosis" and instead recommend that children receive support without waiting for a formal diagnosis.

That recommendation attacks a structural problem head-on: waiting lists for assessment stretch into years in many countries, and support is frequently gated behind a label. If the Danish findings are right that the diagnosed population has simply broadened, then arguing about whether too many children are being diagnosed may be the wrong argument entirely.

Why it matters

• For families: a diagnosis may increasingly describe a child at the milder end of a spectrum, making individualised support more important than the label itself.
• For clinicians: criteria and screening tools calibrated a decade ago may no longer match the population in front of them.
• For researchers: studies that pool decades of diagnoses may be mixing genuinely different populations.
• For policymakers: if identification is broadening rather than prevalence exploding, the answer is capacity — more assessment, more support, less gatekeeping.

What emerges from the converging coverage is not a verdict on whether ADHD and autism are becoming more common, but something more unsettling and more useful: the categories themselves are moving. The children being diagnosed today are, statistically, more ordinary than ever. The question is whether the systems built to support them can keep up.